Chargement en cours...
Hypopigmentation in an African patient treated with imatinib mesylate: a case report.
Imatinib mesylate (STI 571, Gleevec) is a potent bcr-abl tyrosine kinase inhibitor. It also inhibits c-kit tyrosine kinase. Imatinib mesylate is active in the treatment of cronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). It is considered by some authorities to be the standar...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
National Medical Association
2003
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2594583/ https://ncbi.nlm.nih.gov/pubmed/12934870 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|